These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28676094)

  • 41. [Stem cell therapy for intractable skin diseases].
    Tamai K
    Nihon Rinsho; 2011 Dec; 69(12):2167-71. PubMed ID: 22242315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined ultrasound and photoacoustic imaging to noninvasively assess burn injury and selectively monitor a regenerative tissue-engineered construct.
    Nam SY; Chung E; Suggs LJ; Emelianov SY
    Tissue Eng Part C Methods; 2015 Jun; 21(6):557-66. PubMed ID: 25384558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epithelial stem cells in corneal regeneration and epidermal gene therapy.
    Pellegrini G; Rama P; Mavilio F; De Luca M
    J Pathol; 2009 Jan; 217(2):217-28. PubMed ID: 18855878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen.
    Woodley DT; O'Keefe EJ; McDonald JA; Reese MJ; Briggaman RA; Gammon WR
    J Clin Invest; 1987 Jun; 79(6):1826-30. PubMed ID: 3584471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene therapy of inherited skin adhesion disorders: a critical overview.
    De Luca M; Pellegrini G; Mavilio F
    Br J Dermatol; 2009 Jul; 161(1):19-24. PubMed ID: 19466960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapies for genetic extracellular matrix diseases of the skin.
    Nyström A; Bernasconi R; Bornert O
    Matrix Biol; 2018 Oct; 71-72():330-347. PubMed ID: 29274938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal basement membrane: its molecular organization and blistering disorders.
    Masunaga T
    Connect Tissue Res; 2006; 47(2):55-66. PubMed ID: 16754511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy.
    Larcher F; Dellambra E; Rico L; Bondanza S; Murillas R; Cattoglio C; Mavilio F; Jorcano JL; Zambruno G; Del Rio M
    Mol Ther; 2007 Sep; 15(9):1670-6. PubMed ID: 17579576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.
    Liao Y; Itoh M; Yang A; Zhu H; Roberts S; Highet AM; Latshaw S; Mitchell K; van de Ven C; Christiano A; Cairo MS
    Cell Transplant; 2014 Mar; 23(3):303-17. PubMed ID: 23394106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of dermal-epidermal basement membrane zone in skin, cancer, and developmental disorders.
    Ko MS; Marinkovich MP
    Dermatol Clin; 2010 Jan; 28(1):1-16. PubMed ID: 19945611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem cell therapies for recessive dystrophic epidermolysis bullosa.
    Petrova A; Ilic D; McGrath JA
    Br J Dermatol; 2010 Dec; 163(6):1149-56. PubMed ID: 20716209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids.
    Okere B; Alviano F; Costa R; Quaglino D; Ricci F; Dominici M; Paolucci P; Bonsi L; Iughetti L
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):390-402. PubMed ID: 26216908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skin-derived precursors possess the ability of differentiation into the epidermal progeny and accelerate burn wound healing.
    Bayati V; Abbaspour MR; Neisi N; Hashemitabar M
    Cell Biol Int; 2017 Feb; 41(2):187-196. PubMed ID: 27981666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients.
    Kaipe H; Carlson LM; Erkers T; Nava S; Molldén P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringdén O
    Stem Cells Dev; 2015 Jun; 24(12):1471-82. PubMed ID: 25658253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cultured corneal epithelia for ocular surface disease.
    Schwab IR
    Trans Am Ophthalmol Soc; 1999; 97():891-986. PubMed ID: 10703147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regenerative medicine strategies.
    Atala A
    J Pediatr Surg; 2012 Jan; 47(1):17-28. PubMed ID: 22244387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo.
    Vorotnikova E; McIntosh D; Dewilde A; Zhang J; Reing JE; Zhang L; Cordero K; Bedelbaeva K; Gourevitch D; Heber-Katz E; Badylak SF; Braunhut SJ
    Matrix Biol; 2010 Oct; 29(8):690-700. PubMed ID: 20797438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional cells cultured on microcarriers for use in regenerative medicine research.
    Sun LY; Lin SZ; Li YS; Harn HJ; Chiou TW
    Cell Transplant; 2011; 20(1):49-62. PubMed ID: 20887678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [From gene to disease; epidermolysis bullosa due to mutations in proteins in or around the hemidesmosome].
    Jonkman MF; Rulo HF; Duipmans JC
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1108-13. PubMed ID: 12822520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-based therapies for epidermolysis bullosa - from bench to bedside.
    Uitto J; Has C; Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):803-7. PubMed ID: 23107326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.